Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 23 studies | 26% ± 9% | |
mast cell | 19 studies | 28% ± 9% | |
ciliated cell | 19 studies | 48% ± 18% | |
macrophage | 18 studies | 32% ± 12% | |
endothelial cell of lymphatic vessel | 15 studies | 26% ± 8% | |
basal cell | 15 studies | 29% ± 14% | |
epithelial cell | 15 studies | 49% ± 23% | |
endothelial cell | 15 studies | 24% ± 7% | |
type I pneumocyte | 12 studies | 47% ± 13% | |
type II pneumocyte | 12 studies | 36% ± 13% | |
non-classical monocyte | 11 studies | 27% ± 12% | |
microglial cell | 11 studies | 25% ± 11% | |
oligodendrocyte | 11 studies | 32% ± 10% | |
smooth muscle cell | 10 studies | 21% ± 4% | |
goblet cell | 10 studies | 33% ± 10% | |
myeloid cell | 10 studies | 26% ± 9% | |
club cell | 9 studies | 32% ± 12% | |
alveolar macrophage | 8 studies | 28% ± 8% | |
classical monocyte | 8 studies | 26% ± 9% | |
epithelial cell of proximal tubule | 8 studies | 40% ± 20% | |
renal alpha-intercalated cell | 7 studies | 61% ± 17% | |
enterocyte | 7 studies | 47% ± 19% | |
progenitor cell | 7 studies | 31% ± 10% | |
ionocyte | 6 studies | 42% ± 13% | |
kidney loop of Henle epithelial cell | 6 studies | 33% ± 13% | |
natural killer cell | 6 studies | 22% ± 5% | |
CD16-positive, CD56-dim natural killer cell, human | 6 studies | 20% ± 4% | |
retinal rod cell | 6 studies | 30% ± 7% | |
dendritic cell | 6 studies | 32% ± 14% | |
astrocyte | 6 studies | 38% ± 13% | |
respiratory goblet cell | 5 studies | 32% ± 15% | |
secretory cell | 5 studies | 25% ± 15% | |
cholangiocyte | 5 studies | 82% ± 15% | |
endothelial cell of vascular tree | 5 studies | 19% ± 2% | |
B cell | 5 studies | 24% ± 7% | |
brush cell | 5 studies | 68% ± 15% | |
mesothelial cell | 5 studies | 22% ± 4% | |
connective tissue cell | 5 studies | 18% ± 5% | |
monocyte | 5 studies | 24% ± 11% | |
pericyte | 5 studies | 19% ± 4% | |
conventional dendritic cell | 4 studies | 38% ± 14% | |
renal beta-intercalated cell | 4 studies | 67% ± 18% | |
kidney distal convoluted tubule epithelial cell | 4 studies | 45% ± 9% | |
transit amplifying cell | 4 studies | 29% ± 13% | |
abnormal cell | 4 studies | 57% ± 26% | |
adventitial cell | 4 studies | 27% ± 6% | |
cardiac muscle cell | 4 studies | 23% ± 4% | |
memory B cell | 4 studies | 23% ± 5% | |
mature NK T cell | 3 studies | 19% ± 3% | |
extravillous trophoblast | 3 studies | 51% ± 14% | |
intermediate monocyte | 3 studies | 27% ± 13% | |
myofibroblast cell | 3 studies | 19% ± 3% | |
hepatocyte | 3 studies | 34% ± 13% | |
GABAergic neuron | 3 studies | 28% ± 3% | |
glutamatergic neuron | 3 studies | 33% ± 5% | |
pancreatic ductal cell | 3 studies | 85% ± 9% | |
mucus secreting cell | 3 studies | 24% ± 8% | |
adipocyte | 3 studies | 21% ± 2% | |
plasmacytoid dendritic cell | 3 studies | 18% ± 0% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 14 studies | 28% ± 12% | |
kidney | 8 studies | 25% ± 8% | |
intestine | 7 studies | 22% ± 8% | |
brain | 7 studies | 30% ± 10% | |
pancreas | 4 studies | 19% ± 4% | |
peripheral blood | 4 studies | 22% ± 3% | |
placenta | 4 studies | 31% ± 11% | |
eye | 4 studies | 27% ± 5% | |
adipose | 4 studies | 23% ± 4% | |
skin | 3 studies | 19% ± 3% | |
heart | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 5204.57 | 359 / 359 | 100% | 87.09 | 285 / 286 |
intestine | 100% | 5614.80 | 966 / 966 | 99% | 93.01 | 523 / 527 |
kidney | 100% | 7422.34 | 89 / 89 | 99% | 180.96 | 893 / 901 |
lung | 100% | 5805.22 | 578 / 578 | 98% | 47.13 | 1137 / 1155 |
esophagus | 100% | 3673.10 | 1445 / 1445 | 97% | 57.55 | 178 / 183 |
pancreas | 100% | 18475.95 | 328 / 328 | 96% | 182.76 | 171 / 178 |
bladder | 100% | 3877.10 | 21 / 21 | 96% | 52.62 | 484 / 504 |
breast | 100% | 4133.42 | 459 / 459 | 96% | 27.71 | 1071 / 1118 |
liver | 100% | 4361.23 | 226 / 226 | 93% | 74.24 | 376 / 406 |
thymus | 100% | 4372.65 | 653 / 653 | 92% | 31.93 | 558 / 605 |
uterus | 100% | 4627.95 | 170 / 170 | 92% | 47.17 | 423 / 459 |
prostate | 100% | 3641.36 | 245 / 245 | 91% | 22.39 | 455 / 502 |
skin | 100% | 5551.60 | 1809 / 1809 | 86% | 22.83 | 405 / 472 |
ovary | 100% | 3027.53 | 180 / 180 | 83% | 21.74 | 356 / 430 |
adrenal gland | 94% | 2097.21 | 243 / 258 | 23% | 6.08 | 54 / 230 |
adipose | 100% | 4424.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6555.69 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 2177.50 | 241 / 241 | 0% | 0 | 0 / 0 |
brain | 74% | 1107.67 | 1957 / 2642 | 20% | 3.58 | 140 / 705 |
tonsil | 0% | 0 | 0 / 0 | 93% | 26.94 | 42 / 45 |
heart | 76% | 1301.41 | 657 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 76% | 2259.00 | 708 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 69% | 19.68 | 55 / 80 |
muscle | 68% | 904.46 | 550 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 24% | 5.30 | 7 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007219 | Biological process | Notch signaling pathway |
GO_0030855 | Biological process | epithelial cell differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0007165 | Biological process | signal transduction |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0032717 | Biological process | negative regulation of interleukin-8 production |
GO_0005886 | Cellular component | plasma membrane |
GO_0012506 | Cellular component | vesicle membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0070062 | Cellular component | extracellular exosome |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0009986 | Cellular component | cell surface |
GO_0042589 | Cellular component | zymogen granule membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005634 | Cellular component | nucleus |
GO_0005544 | Molecular function | calcium-dependent phospholipid binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0001786 | Molecular function | phosphatidylserine binding |
GO_0048306 | Molecular function | calcium-dependent protein binding |
GO_0004859 | Molecular function | phospholipase inhibitor activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0051059 | Molecular function | NF-kappaB binding |
Gene name | ANXA4 |
Protein name | Annexin A4 (35-beta calcimedin) (Annexin IV) (Annexin-4) (Carbohydrate-binding protein p33/p41) (Chromobindin-4) (Endonexin I) (Lipocortin IV) (P32.5) (PP4-X) (Placental anticoagulant protein II) (PAP-II) (Protein II) Annexin Annexin A4 |
Synonyms | ANX4 |
Description | FUNCTION: Calcium/phospholipid-binding protein which promotes membrane fusion and is involved in exocytosis. . FUNCTION: This protein is an anticoagulant protein that acts as an indirect inhibitor of the thromboplastin-specific complex, which is involved in the blood coagulation cascade. . |
Accessions | ENST00000635311.1 ENST00000472124.1 ENST00000394295.6 [P09525-3] B4E1S2 A0A1Y8EKW3 Q6P452 A0A0U1RRE7 ENST00000468815.1 P09525 ENST00000409920.5 |